These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 9806517)

  • 1. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas.
    Mitsumori M; Shrieve DC; Alexander E; Kaiser UB; Richardson GE; Black PM; Loeffler JS
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):573-80. PubMed ID: 9806517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate side effects of stereotactic radiotherapy and radiosurgery.
    Werner-Wasik M; Rudoler S; Preston PE; Hauck WW; Downes BM; Leeper D; Andrews D; Corn BW; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):299-304. PubMed ID: 10030253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
    Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
    World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of conventional external radiotherapy and stereotactic radiotherapy in the treatment of pituitary adenoma.
    Puataweepong P; Dhanachai M; Dangprasert S; Laothamatas J; Theerapancharoen V; Yongvithisatid P
    J Med Assoc Thai; 2009 Mar; 92(3):382-9. PubMed ID: 19301733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for Pituitary Adenoma Patients Treated with Linac- Based Stereotactic Radiosurgery and Radiotherapy: a Long Term Experience in Thailand.
    Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Swangsilpa T; Vitoonpanich P; Yongvithisatid P
    Asian Pac J Cancer Prev; 2015; 16(13):5279-84. PubMed ID: 26225666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
    Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
    Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosurgery and stereotactic radiotherapy for intracranial meningiomas.
    Torres RC; Frighetto L; De Salles AA; Goss B; Medin P; Solberg T; Ford JM; Selch M
    Neurosurg Focus; 2003 May; 14(5):e5. PubMed ID: 15669816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
    Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
    Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiotherapy for the treatment of pituitary adenomas.
    Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA
    Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
    Graffeo CS; Link MJ; Brown PD; Young WF; Pollock BE
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):618-623. PubMed ID: 29678524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy: High local control and low toxicity in a pooled series.
    Boström JP; Kinfe T; Meyer A; Pintea B; Gerlach R; Surber G; Lammering G; Hamm K
    Strahlenther Onkol; 2015 Jun; 191(6):477-85. PubMed ID: 25575977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    Pomeraniec IJ; Xu Z; Lee CC; Yang HC; Chytka T; Liscak R; Martinez-Alvarez R; Martinez-Moreno N; Attuati L; Picozzi P; Kondziolka D; Mureb M; Bernstein K; Mathieu D; Maillet M; Ogino A; Long H; Kano H; Lunsford LD; Zacharia BE; Mau C; Tuanquin LC; Cifarelli C; Arsanious D; Hack J; Warnick RE; Strickland BA; Zada G; Chang EL; Speckter H; Patel S; Ding D; Sheehan D; Sheehan K; Kvint S; Buch LY; Haber AR; Shteinhart J; Vance ML; Sheehan JP
    J Neurosurg; 2022 Mar; 136(3):813-821. PubMed ID: 34560630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery.
    Yoon SC; Suh TS; Jang HS; Chung SM; Kim YS; Ryu MR; Choi KH; Son HY; Kim MC; Shinn KS
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):849-53. PubMed ID: 9652848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas.
    Selch MT; Ahn E; Laskari A; Lee SP; Agazaryan N; Solberg TD; Cabatan-Awang C; Frighetto L; Desalles AA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):101-11. PubMed ID: 15093905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple fractionated stereotactic radiotherapy of residual pituitary macroadenomas: initial experience.
    Coke C; Andrews DW; Corn BW; Werner-Wasik M; Downes B; McCune C; Curran WJ
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):183-90. PubMed ID: 9711753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinological outcome after pituitary transposition (hypophysopexy) and adjuvant radiotherapy for tumors involving the cavernous sinus.
    Taussky P; Kalra R; Coppens J; Mohebali J; Jensen R; Couldwell WT
    J Neurosurg; 2011 Jul; 115(1):55-62. PubMed ID: 21395389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study.
    Xu Z; Ellis S; Lee CC; Starke RM; Schlesinger D; Lee Vance M; Lopes MB; Sheehan J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):903-10. PubMed ID: 25216855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: focus on complications.
    Hauptman JS; Barkhoudarian G; Safaee M; Gorgulho A; Tenn S; Agazaryan N; Selch M; De Salles AA
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):542-51. PubMed ID: 22137019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
    Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
    Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.